Evidence-based foodplatform, geschreven door professionals

De voedingsindustrie houdt je soms voor de gek met misleidende etiketten en voedingsclaims op fabrieksproducten. Daarnaast is op het internet veel onjuiste informatie over voeding te vinden. Tijd voor een onderbouwd tegengeluid! I’m a Foodie is hét platform waarop diëtisten en voedings- en gezondheidswetenschappers hun kennis delen over gezonde voeding.
Wij staan voor gezond, duurzaam, vers (zonder pakjes en zakjes) en zelf koken. De onderwerpen zijn alledaags, evidence based én direct praktisch toepasbaar in je eigen situatie. Uiteindelijk is de keuze aan jou: op welke manier ga jij gezond eten?

Referenties uit Eet als een expert

Referenties uit Eet als een expert 2016-12-19T03:30:49+00:00
Wij onderbouwen al onze claims met wetenschappelijk onderzoek. Alle referenties uit ons boek Eet als een expert kan je op deze pagina terugvinden.
  1. Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008;25:2097–116.
  2. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 2001;345:790–7.
  3. Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M, Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784–93.
  4. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med. 2000;343:16–22.
  5. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br. J. Cancer 2011;105 Suppl 2:S77–81.
  6. Gezondheidsmonitor GGD’en, CBS en RIVM – Nationaal Kompas Volksgezondheid [Internet]. [cited 2016 Mar 10];Available from: http://www.nationaalkompas.nl/algemeen/meta-informatie/bronbeschrijvingen/achtergronddocument-gezondheidsmonitor
  7. Van Rossum C, Fransen HP, Verkaik-Kloosterman J, Buurma-Rethans E, Ocké MC. Dutch National Food Consumption Survey 2007-2010: Diet of children and adults aged 7 to 69 years. RIVM rapport 350050006 [Internet] 2011;Available from: http://rivm.openrepository.com/rivm/handle/10029/261553
  8. Jacobs DR, Tapsell LC. Food synergy: the key to a healthy diet. Proc. Nutr. Soc. 2013;72:200–6.
  9. Tognon G, Lissner L, Sæbye D, Walker KZ, Heitmann BL. The Mediterranean diet in relation to mortality and CVD: a Danish cohort study. Br. J. Nutr. 2014;111:151–9.
  10. Kontogianni MD, Panagiotakos DB. Dietary patterns and stroke: a systematic review and re-meta-analysis. Maturitas 2014;79:41–7.
  11. InterAct Consortium, Romaguera D, Guevara M, Norat T, Langenberg C, Forouhi NG, et al. Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care 2011;34:1913–8.
  12. Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int. J. Cancer 2014;135:1884–97.
  13. Martinez-Gonzalez MA, Bes-Rastrollo M. Dietary patterns, Mediterranean diet, and cardiovascular disease. Curr. Opin. Lipidol. 2014;25:20–6.
  14. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014;17:2769–82.
  15. Esposito K, Chiodini P, Maiorino MI, Bellastella G, Panagiotakos D, Giugliano D. Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine 2014;47:107–16.
  16. InterAct Consortium. Adherence to predefined dietary patterns and incident type 2 diabetes in European populations: EPIC-InterAct Study. Diabetologia 2014;57:321–33.
  17. Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases–incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition 2013;29:611–8.
  18. de Ruyter JC, Olthof MR, Seidell JC, Katan MB. A trial of sugar-free or sugar-sweetened beverages and body weight in children. N. Engl. J. Med. 2012;367:1397–406.
  19. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N. Engl. J. Med. 1987;317:1303–9.
  20. Szajewska H, Ruszczynski M. Systematic review demonstrating that breakfast consumption influences body weight outcomes in children and adolescents in Europe. Crit. Rev. Food Sci. Nutr. 2010;50:113–9.
  21. Rampersaud GC. Benefits of Breakfast for Children and Adolescents: Update and Recommendations for Practitioners. Am. J. Lifestyle Med. 2009;3:86–103.
  22. Casazza K, Brown A, Astrup A, Bertz F, Baum C, Brown MB, et al. Weighing the Evidence of Common Beliefs in Obesity Research. Crit. Rev. Food Sci. Nutr. 2015;55:2014–53.
  23. Brown AW, Bohan Brown MM, Allison DB. Belief beyond the evidence: using the proposed effect of breakfast on obesity to show 2 practices that distort scientific evidence. Am. J. Clin. Nutr. 2013;98:1298–308.
  24. Rampersaud GC, Pereira MA, Girard BL, Adams J, Metzl JD. Breakfast habits, nutritional status, body weight, and academic performance in children and adolescents. J. Am. Diet. Assoc. 2005;105:743–60; quiz 761–2.
  25. Littlecott HJ, Moore GF, Moore L, Lyons RA, Murphy S. Association between breakfast consumption and educational outcomes in 9-11-year-old children. Public Health Nutr. 2015;1–8.
  26. Liu S, Sesso HD, Manson JE, Willett WC, Buring JE. Is intake of breakfast cereals related to total and cause-specific mortality in men? Am. J. Clin. Nutr. 2003;77:594–9.
  27. Steffen LM, Jacobs DR Jr, Stevens J, Shahar E, Carithers T, Folsom AR. Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 2003;78:383–90.
  28. Jensen MK, Koh-Banerjee P, Hu FB, Franz M, Sampson L, Grønbaek M, et al. Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am. J. Clin. Nutr. 2004;80:1492–9.
  29. Anderson JW, Hanna TJ, Xuejun P, Kryscio RJ. Whole Grain Foods and Heart Disease Risk. J. Am. Coll. Nutr. 2000;19:291S – 299S.
  30. Jacobs DR, Leonard M, Joanne S, Kushi LH. Whole‐grain intake and cancer: An expanded review and meta‐analysis. Nutr. Cancer 1998;30:85–96.
  31. Aune D, Chan DSM, Lau R, Vieira R, Greenwood DC, Kampman E, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011;343:d6617.
  32. Haas P, Machado MJ, Anton AA, Silva ASS, de Francisco A. Effectiveness of whole grain consumption in the prevention of colorectal cancer: meta-analysis of cohort studies. Int. J. Food Sci. Nutr. 2009;60 Suppl 6:1–13.
  33. Kyrø C, Cecilie K, Guri S, Steffen L, Rikard L, Jane C, et al. Intake of whole grains from different cereal and food sources and incidence of colorectal cancer in the Scandinavian HELGA cohort. Cancer Causes Control 2013;24:1363–74.
  34. Aune D, Dagfinn A, Teresa N, Pål R, Vatten LJ. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013;28:845–58.
  35. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J. Nutr. 2012;142:1304–13.
  36. Hollænder PLB, Ross AB, Kristensen M. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. Am. J. Clin. Nutr. 2015;102:556–72.
  37. Wanders AJ, van den Borne JJGC, de Graaf C, Hulshof T, Jonathan MC, Kristensen M, et al. Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obes. Rev. 2011;12:724–39.
  38. Etiology and evaluation of chronic constipation in adults [Internet]. [cited 2015 Dec 24];Available from: http://www.uptodate.com/contents/etiology-and-evaluation-of-chronic-constipation-in-adults
  39. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, et al. Health benefits of dietary fiber. Nutr. Rev. 2009;67:188–205.
  40. Threapleton DE, Greenwood DC, Evans CEL, Cleghorn CL, Nykjaer C, Woodhead C, et al. Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke 2013;44:1360–8.
  41. Chen G-C, Lv D-B, Pang Z, Dong J-Y, Liu Q-F. Dietary fiber intake and stroke risk: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2013;67:96–100.
  42. Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, et al. Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC). PLoS One 2012;7:e39361.
  43. Yao B, Fang H, Xu W, Yan Y, Xu H, Liu Y, et al. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur. J. Epidemiol. 2014;29:79–88.
  44. Aune D, Chan DSM, Greenwood DC, Vieira AR, Rosenblatt DAN, Vieira R, et al. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann. Oncol. 2012;23:1394–402.
  45. Wu Y, Qian Y, Pan Y, Li P, Yang J, Ye X, et al. Association between dietary fiber intake and risk of coronary heart disease: A meta-analysis. Clin. Nutr. 2015;34:603–11.
  46. Threapleton DE, Greenwood DC, Evans CEL, Cleghorn CL, Nykjaer C, Woodhead C, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2013;347:f6879.
  47. Yang Y, Zhao L-G, Wu Q-J, Ma X, Xiang Y-B. Association between dietary fiber and lower risk of all-cause mortality: a meta-analysis of cohort studies. Am. J. Epidemiol. 2015;181:83–91.
  48. Wolever TMS. Do whole grain cereals really reduce LDL-cholesterol by 0.72 mmol/L? J. Nutr. 2013;143:1521–2.
  49. Ripsin CM, Keenan JM, Jacobs DR Jr, Elmer PJ, Welch RR, Van Horn L, et al. Oat products and lipid lowering. A meta-analysis. JAMA 1992;267:3317–25.
  50. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am. J. Clin. Nutr. 1999;69:30–42.
  51. AbuMweis SS, Jew S, Ames NP. β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials. Eur. J. Clin. Nutr. 2010;64:1472–80.
  52. Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI. The effects of barley-derived soluble fiber on serum lipids. Ann. Fam. Med. 2009;7:157–63.
  53. Whitehead A, Beck EJ, Tosh S, Wolever TMS. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014;100:1413–21.
  54. Kelly SAM, Summerbell CD, Brynes A, Whittaker V, Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst. Rev. 2007;CD005051.
  55. EFSA Panel on Dietetic Products NAA (nda). Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/20061 [Internet]. 2010;Available from: http://dx.doi.org/10.2903/j.efsa.2010.1885
  56. Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 2015;351:h4183.
  57. Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, et al. Calcium intake and risk of fracture: systematic review. BMJ 2015;351:h4580.
  58. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257–64.
  59. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2009;169:551–61.
  60. Aune D, Lau R, Chan DSM, Vieira R, Greenwood DC, Kampman E, et al. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann. Oncol. 2012;23:37–45.
  61. Ralston RA, Truby H, Palermo CE, Walker KZ. Colorectal cancer and nonfermented milk, solid cheese, and fermented milk consumption: a systematic review and meta-analysis of prospective studies. Crit. Rev. Food Sci. Nutr. 2014;54:1167–79.
  62. Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson JE, Willett WC, et al. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med. 2014;12:215.
  63. O’Connor LM, Lentjes MAH, Luben RN, Khaw K-T, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 2014;57:909–17.
  64. Qin L-Q, Xu J-Y, Han S-F, Zhang Z-L, Zhao Y-Y, Szeto IM. Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies. Asia Pac. J. Clin. Nutr. 2015;24:90–100.
  65. Dong J-Y, Zhang L, He K, Qin L-Q. Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies. Breast Cancer Res. Treat. 2011;127:23–31.
  66. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Dairy foods and risk of stroke: a meta-analysis of prospective cohort studies. Nutr. Metab. Cardiovasc. Dis. 2014;24:460–9.
  67. Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Kanis JA, Orav EJ, Staehelin HB, et al. Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. J. Bone Miner. Res. 2011;26:833–9.
  68. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, Willett WC, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2011;93:158–71.
  69. Activity P. and the Prevention. Available from: http://www.wcrf.org/sites/default/files/Second-Expert-Report.pdf
  70. With IP. Diet, nutrition, physical activity and prostate cancer. Available from: http://www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf
  71. Mensink RP, Zock PL, Kester ADM, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003;77:1146–55.
  72. Katan MB, Zock PL, Mensink RP. Effects of fats and fatty acids on blood lipids in humans: an overview. Am. J. Clin. Nutr. 1994;60:1017S – 1022S.
  73. Gebauer SK, Destaillats F, Dionisi F, Krauss RM, Baer DJ. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am. J. Clin. Nutr. 2015;102:1339–46. *Deze referentie hoort niet op bij p29
  74. Michaëlsson K, Wolk A, Langenskiöld S, Basu S, Warensjö Lemming E, Melhus H, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ 2014;349:g6015.
  75. Larsson SC, Crippa A, Orsini N, Wolk A, Michaëlsson K. Milk Consumption and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis. Nutrients 2015;7:7749–63.
  76. Dong J-Y, Qin L-Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res. Treat. 2011;125:315–23.
  77. Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, et al. Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One 2013;8:e81968.
  78. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J. Am. Coll. Nutr. 2011;30:79–91.
  79. Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst. Rev. 2013;12:CD001395.
  80. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am. J. Clin. Nutr. 2009;89:1155–63.
  81. EFSA. Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA Journal 2015;13:4246.
  82. Grodstein F, O’Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, et al. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann. Intern. Med. 2013;159:806–14.
  83. Macpherson H, Pipingas A, Pase MP. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2013;97:437–44.
  84. Macpherson H, Pipingas A, Pase MP. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2013;97:437–44.
  85. Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010;341:c5702.
  86. Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst. Rev. 2006;CD004639.
  87. van Mierlo LAJ, Arends LR, Streppel MT, Zeegers MPA, Kok FJ, Grobbee DE, et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J. Hum. Hypertens. 2006;20:571–80.
  88. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.
  89. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N. Engl. J. Med. 1994;330:1029–35.
  90. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 1995;62:1427S – 1430S.
  91. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:307–20.
  92. Mensink GBM, Fletcher R, Gurinovic M, Huybrechts I, Lafay L, Serra-Majem L, et al. Mapping low intake of micronutrients across Europe. Br. J. Nutr. 2013;110:755–73.
  93. Veel te hoge doses B6 in vitaminepillen | Consumentenbond [Internet]. [cited 2016 Jan 3];Available from: http://www.consumentenbond.nl/voedingssupplementen/nieuws1/2014/veel-te-hoge-doses-b6-in-vitaminepillen/
  94. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am. J. Clin. Nutr. 2009;90:288–97.
  95. Cressey P, Saunders D, Goodman J. Cyanogenic glycosides in plant-based foods available in New Zealand. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2013;30:1946–53.
  96. Bolarinwa IF, Orfila C, Morgan MRA. Amygdalin content of seeds, kernels and food products commercially-available in the UK. Food Chem. 2014;152:133–9.
  97. Evaluations of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) [Internet]. [cited 2015 Dec 27];Available from: http://apps.who.int/food-additives-contaminants-jecfa-database/PrintPreview.aspx?chemID=1086
  98. He FJ, Nowson CA, Lucas M, MacGregor GA. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J. Hum. Hypertens. 2007;21:717–28.
  99. Crowe FL, Roddam AW, Key TJ, Appleby PN, Overvad K, Jakobsen MU, et al. Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur. Heart J. 2011;32:1235–43.
  100. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke 2014;45:1613–9.
  101. Aune D, Lau R, Chan DSM, Vieira R, Greenwood DC, Kampman E, et al. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011;141:106–18.
  102. Cooper AJ, Forouhi NG, Ye Z, Buijsse B, Arriola L, Balkau B, et al. Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur. J. Clin. Nutr. 2012;66:1082–92.
  103. Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ 2010;341:c4229.
  104. Büchner FL, Bueno-de-Mesquita HB, Ros MM, Overvad K, Dahm CC, Hansen L, et al. Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev. 2010;19:2278–86.
  105. Lam TK, Gallicchio L, Lindsley K, Shiels M, Hammond E, Tao XG, et al. Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol. Biomarkers Prev. 2009;18:184–95.
  106. Takata Y, Xiang Y-B, Yang G, Li H, Gao J, Cai H, et al. Intakes of Fruits, Vegetables, and Related Vitamins and Lung Cancer Risk: Results from the Shanghai Men’s Health Study (2002–2009). Nutr. Cancer 2013;65:51–61.
  107. Dangour AD, Dodhia SK, Hayter A, Allen E, Lock K, Uauy R. Nutritional quality of organic foods: a systematic review. Am. J. Clin. Nutr. 2009;90:680–5.
  108. Brandt K, Leifert C, Sanderson R, Seal CJ. Agroecosystem Management and Nutritional Quality of Plant Foods: The Case of Organic Fruits and Vegetables. CRC Crit. Rev. Plant Sci. 2011;30:177–97.
  109. Smith-Spangler C, Brandeau ML, Hunter GE, Bavinger JC, Pearson M, Eschbach PJ, et al. Are organic foods safer or healthier than conventional alternatives?: a systematic review. Ann. Intern. Med. 2012;157:348–66.
  110. Barański M, Srednicka-Tober D, Volakakis N, Seal C, Sanderson R, Stewart GB, et al. Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analyses. Br. J. Nutr. 2014;112:794–811.
  111. Dangour AD, Lock K, Hayter A, Aikenhead A, Allen E, Uauy R. Nutrition-related health effects of organic foods: a systematic review. Am. J. Clin. Nutr. 2010;92:203–10.
  112. Baxter JH. Absorption of chlorophyll phytol in normal man and in patients with Refsum’s disease. J. Lipid Res. 1968;9:636–41.
  113. Consumentenbond. Superfoods: de claims. Consumentenbond Gezondgids2014;
  114. Beer BJ, van Vugt MA. Teksten warenwet 2014/2015. 2014.
  115. Geurts M, Verkaik-Kloosterman J. De jodiuminname van de Nederlandse bevolking na verdere zoutverlaging in brood. RIVM briefrapport 2014-0054 [Internet] 2014;Available from: http://rivm.openrepository.com/rivm/handle/10029/557054
  116. Andersson M, De Benoist B, Darnton-Hill I, Delange F, Others. Iodine deficiency in Europe: a continuing public health problem. World Health Organization Geneva; 2007.
  117. Brouns FJPH, van Buul VJ, Shewry PR. Does wheat make us fat and sick? J. Cereal Sci. 2013;58:209–15.
  118. Jones J. Wheat Belly —An Analysis of Selected Statements and Basic Theses from the Book. Cereal Foods World 2012;57:177–89.
  119. Green PHR, Jabri B. Coeliac disease. Lancet 2003;362:383–91.
  120. Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A, et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013;5:3839–53.
  121. Naude CE, Schoonees A, Senekal M, Young T, Garner P, Volmink J. Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis. PLoS One 2014;9:e100652.
  122. Shah M, Garg A. High-fat and high-carbohydrate diets and energy balance. Diabetes Care 1996;19:1142–52.
  123. Bravata DM, Sanders L, Huang J, Krumholz HM, Olkin I, Gardner CD, et al. Efficacy and Safety of Low-Carbohydrate Diets: A Systematic Review. JAMA 2003;289:1837.
  124. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am. J. Clin. Nutr. 2013;98:1066–83.
  125. Gibson RA, Makrides M, Smithers LG, Voevodin M, Sinclair AJ. The effect of dairy foods on CHD: a systematic review of prospective cohort studies. Br. J. Nutr. 2009;102:1267–75.
  126. de Goede J, Geleijnse JM, Ding EL, Soedamah-Muthu SS. Effect of cheese consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 2015;73:259–75.
  127. Van Rossum C, Buurma-Rethans E, Fransen HP, Verkaik-Kloosterman J, Hendriksen M. Zoutconsumptie van kinderen en volwassenen in Nederland: Resultaten uit de Voedselconsumptiepeiling 2007-2010. RIVM rapport 350050007 [Internet] 2012;Available from: http://rivm.openrepository.com/rivm/handle/10029/261552
  128. Shaper AG, Wannamethee G, Walker M. Milk, butter, and heart disease. BMJ 1991;302:785–6.
  129. Goldbohm RA, Chorus AMJ, Galindo Garre F, Schouten LJ, van den Brandt PA. Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am. J. Clin. Nutr. 2011;93:615–27.
  130. Sonestedt E, Wirfält E, Wallström P, Gullberg B, Orho-Melander M, Hedblad B. Dairy products and its association with incidence of cardiovascular disease: the Malmö diet and cancer cohort. Eur. J. Epidemiol. 2011;26:609–18.
  131. Avalos EE, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Bergstrom JN, Al-Delaimy WK. Is dairy product consumption associated with the incidence of CHD? Public Health Nutr. 2013;16:2055–63.
  132. Patterson E, Larsson SC, Wolk A, Åkesson A. Association between dairy food consumption and risk of myocardial infarction in women differs by type of dairy food. J. Nutr. 2013;143:74–9.
  133. Zock PL, Katan MB. Butter, margarine and serum lipoproteins. Atherosclerosis 1997;131:7–16.
  134. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252.
  135. Is roomboter, margarine of halvarine beter voor mijn kind? | Voedingscentrum [Internet]. [cited 2016 Jan 10];Available from: http://www.voedingscentrum.nl/nl/service/vraag-en-antwoord/kinderen-en-jongeren/is-roomboter-margarine-of-halvarine-beter-voor-mijn-kind-.aspx
  136. Weggemans RM, Zock PL, Katan MB. Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am. J. Clin. Nutr. 2001;73:885–91.
  137. Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z, et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ 2013;346:e8539.
  138. Shin JY, Xun P, Nakamura Y, He K. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am. J. Clin. Nutr. 2013;98:146–59.
  139. Li Y, Zhou C, Zhou X, Li L. Egg consumption and risk of cardiovascular diseases and diabetes: a meta-analysis. Atherosclerosis 2013;229:524–30.
  140. Tran NL, Barraj LM, Heilman JM, Scrafford CG. Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature. Diabetes Metab. Syndr. Obes. 2014;7:121–37.
  141. van Asselt ED, van Bussel LGJ, van Horne P, van der Voet H, van der Heijden GWAM, van der Fels-Klerx HJ. Assessing the sustainability of egg production systems in The Netherlands. Poult. Sci. 2015;94:1742–50.
  142. Bellisle F, McDevitt R, Prentice AM. Meal frequency and energy balance. Br. J. Nutr. 1997;77 Suppl 1:S57–70.
  143. Palmer MA, Capra S, Baines SK. Association between eating frequency, weight, and health. Nutr. Rev. 2009;67:379–90.
  144. Ivoren Kruis [Internet]. [cited 2016 Jan 10];Available from: http://www.ivorenkruis.nl/index.cfm?t=keyword.cfm&folder=25
  145. PAHO. Ultra-processed food and drink products in Latin America: Trends, impact on obesity, policy implications. 2015;Available from: http://iris.paho.org/xmlui/bitstream/handle/123456789/7699/9789275118641_eng.pdf?sequence=5&isAllowed=y&ua=1
  146. Monteiro CA, Moubarac J-C, Cannon G, Ng SW, Popkin B. Ultra-processed products are becoming dominant in the global food system. Obes. Rev. 2013;14 Suppl 2:21–8.
  147. Moubarac J-C, Martins APB, Claro RM, Levy RB, Cannon G, Monteiro CA. Consumption of ultra-processed foods and likely impact on human health. Evidence from Canada. Public Health Nutr. 2013;16:2240–8.
  148. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 2011;364:2392–404.
  149. Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, Thamarangsi T, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet 2013;381:670–9.
  150. MVO. MEMO Consumptie aantal voedingsmiddelengroepen en nutrienten voor Gezondheidsraad. 2015;Available from: http://www.mvo.nl/media/vette_feiten/memo_consumptie_aantal_voedingsmiddelengroepen_en_nutrienten_voor_gezondheidsraad.pdf
  151. Te Morenga LA, Howatson AJ, Jones RM, Mann J. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am. J. Clin. Nutr. 2014;100:65–79.
  152. 9789241549028_eng.pdf. Available from: http://apps.who.int/iris/bitstream/10665/149782/1/9789241549028_eng.pdf
  153. Moynihan PJ, Kelly SAM. Effect on caries of restricting sugars intake: systematic review to inform WHO guidelines. J. Dent. Res. 2014;93:8–18.
  154. Sievenpiper JL, Tappy L, Brouns F. Fructose as a Driver of Diabetes: An Incomplete View of the Evidence. Mayo Clin. Proc. 2015;90:984–8.
  155. Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann. Intern. Med. 2012;156:291–304.
  156. Adan RAH, Vanderschuren LJMJ. Eating addiction? The nerves and fibers that control food intake. Utrecht University; 2015.
  157. Consensus. [cited 2016 Mar 10];Available from: http://www.neurofast.eu/consensus
  158. Foods List [Internet]. [cited 2016 Jan 12];Available from: http://ndb.nal.usda.gov/ndb/search
  159. Mijn Voedingscentrum [Internet]. [cited 2016 Jan 12];Available from: https://mijn.voedingscentrum.nl/nl/eetmeter/
  160. NEVO [Internet]. [cited 2015 Nov 29];Available from: http://nevo-online.rivm.nl/ProductenZoeken.aspx
  161. Purnomo H. Sugar components of coconut sugar in Indonesia. ASEAN Food J. [Internet] 1992;Available from: http://www.cabdirect.org/abstracts/19930319960.html
  162. de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015;351:h3978.
  163. Zevenbergen H, de Bree A, Zeelenberg M, Laitinen K, van Duijn G, Flöter E. Foods with a high fat quality are essential for healthy diets. Ann. Nutr. Metab. 2009;54 Suppl 1:15–24.
  164. Fattore E, Bosetti C, Brighenti F, Agostoni C, Fattore G. Palm oil and blood lipid–related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials. Am. J. Clin. Nutr. 2014;99:1331–50.
  165. Sun Y, Neelakantan N, Wu Y, Lote-Oke R, Pan A, van Dam RM. Palm Oil Consumption Increases LDL Cholesterol Compared with Vegetable Oils Low in Saturated Fat in a Meta-Analysis of Clinical Trials. J. Nutr. 2015;145:1549–58.
  166. Palm Oil Fact Sheet [Internet]. Rainforest Action Network [cited 2016 Jan 10];Available from: http://ran.org/problem-palm-oil-factsheet
  167. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J. Nutr. 2006;136:2588–93.
  168. Gan Y, Tong X, Li L, Cao S, Yin X, Gao C, et al. Consumption of fruit and vegetable and risk of coronary heart disease: a meta-analysis of prospective cohort studies. Int. J. Cardiol. 2015;183:129–37.
  169. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke 2014;45:1613–9.
  170. Wu Y, Zhang D, Jiang X, Jiang W. Fruit and vegetable consumption and risk of type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies. Nutr. Metab. Cardiovasc. Dis. 2015;25:140–7.
  171. Muraki I, Imamura F, Manson JE, Hu FB, Willett WC, van Dam RM, et al. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ 2013;347:f5001.
  172. Li M, Fan Y, Zhang X, Hou W, Tang Z. Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open 2014;4:e005497.
  173. Aune D, Lau R, Chan DSM, Vieira R, Greenwood DC, Kampman E, et al. Nonlinear Reduction in Risk for Colorectal Cancer by Fruit and Vegetable Intake Based on Meta-analysis of Prospective Studies. Gastroenterology 2011;141:106–18.
  174. Büchner FL, Bueno-de-Mesquita HB, Linseisen J, Boshuizen HC, Kiemeney LALM, Ros MM, et al. Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2010;21:357–71.
  175. Vieira AR, Abar L, Vingeliene S, Chan DSM, Aune D, Navarro-Rosenblatt D, et al. Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann. Oncol. 2016;27:81–96.
  176. Del Rio D, Rodriguez-Mateos A, Spencer JPE, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2013;18:1818–92.
  177. Wahlqvist ML. Antioxidant relevance to human health. Asia Pac. J. Clin. Nutr. 2013;22:171–6.
  178. Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One 2013;8:e56803.
  179. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012;3:CD007176.
  180. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 2003;78:517S – 520S.
  181. Seeram NP, Aviram M, Zhang Y, Henning SM, Feng L, Dreher M, et al. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric. Food Chem. 2008;56:1415–22.
  182. The Truth About Oprah, Dr. Oz, Acai, Resveratrol, Colon Cleanse and More [Internet]. Oprah.com [cited 2015 Oct 31];Available from: http://www.oprah.com/health/The-Truth-About-Oprah-Dr-Oz-Acai-Resveratrol-and-Colon-Cleanse
  183. Zhang Z, Xu G, Liu D, Zhu W, Fan X, Liu X. Dietary fiber consumption and risk of stroke. Eur. J. Epidemiol. 2013;28:119–30.
  184. Dong J-Y, He K, Wang P, Qin L-Q. Dietary fiber intake and risk of breast cancer: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2011;94:900–5.
  185. Ferrari P, Rinaldi S, Jenab M, Lukanova A, Olsen A, Tjønneland A, et al. Dietary fiber intake and risk of hormonal receptor–defined breast cancer in the European Prospective Investigation into Cancer and Nutrition study. Am. J. Clin. Nutr. 2013;97:344–53.
  186. Flood-Obbagy JE, Rolls BJ. The effect of fruit in different forms on energy intake and satiety at a meal. Appetite 2009;52:416–22.
  187. Sabaté J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch. Intern. Med. 2010;170:821–7.
  188. Blanco Mejia S, Kendall CWC, Viguiliouk E, Augustin LS, Ha V, Cozma AI, et al. Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 2014;4:e004660.
  189. Del Gobbo LC, Falk MC, Feldman R, Lewis K, Mozaffarian D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am. J. Clin. Nutr. 2015;102:1347–56.
  190. Zhou D, Yu H, He F, Reilly KH, Zhang J, Li S, et al. Nut consumption in relation to cardiovascular disease risk and type 2 diabetes: a systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 2014;100:270–7.
  191. Luo C, Zhang Y, Ding Y, Shan Z, Chen S, Yu M, et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am. J. Clin. Nutr. 2014;100:256–69.
  192. Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am. J. Clin. Nutr. 2014;100:278–88.
  193. Mayhew AJ, de Souza RJ, Meyre D, Anand SS, Mente A. A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. Br. J. Nutr. 2016;115:212–25.
  194. Fogelholm M, Anderssen S, Gunnarsdottir I, Lahti-Koski M. Dietary macronutrients and food consumption as determinants of long-term weight change in adult populations: a systematic literature review. Food Nutr. Res. [Internet] 2012;56. Available from: http://dx.doi.org/10.3402/fnr.v56i0.19103
  195. Flores-Mateo G, Rojas-Rueda D, Basora J, Ros E, Salas-Salvadó J. Nut intake and adiposity: meta-analysis of clinical trials. Am. J. Clin. Nutr. 2013;97:1346–55.
  196. Mattes RD, Kris-Etherton PM, Foster GD. Impact of peanuts and tree nuts on body weight and healthy weight loss in adults. J. Nutr. 2008;138:1741S – 1745S.
  197. Natoli S, McCoy P. A review of the evidence: nuts and body weight. Asia Pac. J. Clin. Nutr. 2007;16:588–97.
  198. Secor CL, Lisk DJ. VARIATION IN THE SELENIUM CONTENT OF INDIVIDUAL BRAZIL NUTS. J. Food Saf. 1989;9:279–81.
  199. Chang JC, Gutenmann WH, Reid CM, Lisk DJ. Selenium content of Brazil nuts from two geographic locations in Brazil. Chemosphere 1995;30:801–2.
  200. Pacheco AM, Scussel VM. Selenium and aflatoxin levels in raw Brazil nuts from the Amazon basin. J. Agric. Food Chem. 2007;55:11087–92.
  201. Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst. Rev. 2012;8:CD008893.
  202. Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E, et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 2011;343:d4488.
  203. Kerimi A, Williamson G. The cardiovascular benefits of dark chocolate. Vascul. Pharmacol. 2015;71:11–5.
  204. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D. Catechin intake and associated dietary and lifestyle factors in a representative sample of Dutch men and women. Eur. J. Clin. Nutr. 2001;55:76–81.
  205. Jéquier E, Constant F. Water as an essential nutrient: the physiological basis of hydration. Eur. J. Clin. Nutr. 2010;64:115–23.
  206. Meinders A-J, Meinders AE. Hoeveel water moeten we eigenlijk drinken. Ned. Tijdschr. Geneeskd. 2010;154:A1757.
  207. Popkin BM, D’Anci KE, Rosenberg IH. Water, hydration, and health. Nutr. Rev. 2010;68:439–58.
  208. Pan A, Hu FB. Effects of carbohydrates on satiety: differences between liquid and solid food. Curr. Opin. Clin. Nutr. Metab. Care 2011;14:385–90.
  209. Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am. J. Clin. Nutr. 2013;98:1084–102.
  210. Greenwood DC, Threapleton DE, Evans CEL, Cleghorn CL, Nykjaer C, Woodhead C, et al. Association between sugar-sweetened and artificially sweetened soft drinks and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies. Br. J. Nutr. 2014;112:725–34.
  211. Malik VS, Popkin BM, Bray GA, Després J-P, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010;121:1356–64.
  212. Xi B, Bo X, Shuangshuang L, Zhaolu L, Huan T, Xiuxiu Y, et al. Intake of Fruit Juice and Incidence of Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS One 2014;9:e93471.
  213. Imamura F, O’Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ 2015;351:h3576.
  214. Johnstone AM. Fasting – the ultimate diet? Obes. Rev. 2007;8:211–22.
  215. Mallikarjun S, Sieburth RM. Aspartame and Risk of Cancer: A Meta-analytic Review. Arch. Environ. Occup. Health 2015;70:133–41.
  216. Marinovich M, Galli CL, Bosetti C, Gallus S, La Vecchia C. Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues. Food Chem. Toxicol. 2013;60:109–15.
  217. McCullough ML, Teras LR, Shah R, Diver WR, Gaudet MM, Gapstur SM. Artificially and sugar-sweetened carbonated beverage consumption is not associated with risk of lymphoid neoplasms in older men and women. J. Nutr. 2014;144:2041–9.
  218. Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WC, Feskanich D. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am. J. Clin. Nutr. 2012;96:1419–28.
  219. Bosetti C, Gallus S, Talamini R, Montella M, Franceschi S, Negri E, et al. Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy. Cancer Epidemiol. Biomarkers Prev. 2009;18:2235–8.
  220. Gallus S, Scotti L, Negri E, Talamini R, Franceschi S, Montella M, et al. Artificial sweeteners and cancer risk in a network of case-control studies. Ann. Oncol. 2007;18:40–4.
  221. Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon R, et al. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol. Biomarkers Prev. 2006;15:1654–9.
  222. Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive | European Food Safety Authority [Internet]. [cited 2016 Feb 13];Available from: http://www.efsa.europa.eu/en/efsajournal/pub/3496
  223. Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ. Health Perspect. 2007;115:1293–7.
  224. European Food Safety Authority (EFSA). Statement of EFSA on the scientific evaluation of two studies related to the safety of artificial sweeteners [Internet]. 2011;Available from: http://dx.doi.org/10.2903/j.efsa.2011.2089
  225. Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive | European Food Safety Authority [Internet]. [cited 2016 Jan 17];Available from: http://www.efsa.europa.eu/en/efsajournal/pub/3496
  226. Sweeteners | European Food Safety Authority [Internet]. [cited 2016 Mar 10];Available from: http://www.efsa.europa.eu/en/topics/topic/sweeteners
  227. Fitch C, Keim KS, Academy of Nutrition and Dietetics. Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. J. Acad. Nutr. Diet. 2012;112:739–58.
  228. Shankar P, Ahuja S, Sriram K. Non-nutritive sweeteners: review and update. Nutrition 2013;29:1293–9.
  229. Vermunt SHF, Pasman WJ, Schaafsma G, Kardinaal AFM. Effects of sugar intake on body weight: a review. Obes. Rev. 2003;4:91–9.
  230. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671.
  231. Padilla H, Michael Gaziano J, Djoussé L. Alcohol consumption and risk of heart failure: a meta-analysis. Phys. Sportsmed. 2010;38:84–9.
  232. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009;32:2123–32.
  233. Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005;28:719–25.
  234. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch. Intern. Med. 2006;166:2437–45.
  235. Ferrari P, Licaj I, Muller DC, Kragh Andersen P, Johansson M, Boeing H, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study. BMJ Open 2014;4:e005245.
  236. Jayasekara H, English DR, Room R, MacInnis RJ. Alcohol consumption over time and risk of death: a systematic review and meta-analysis. Am. J. Epidemiol. 2014;179:1049–59.
  237. Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry 2009;17:542–55.
  238. Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann. Epidemiol. 2007;17:S16–23.
  239. Hansel B, Kontush A, Bruckert E. Is a cardioprotective action of alcohol a myth? Curr. Opin. Cardiol. 2012;27:550–5.
  240. Roerecke M, Rehm J. Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am. J. Epidemiol. 2011;173:245–58.
  241. Stockwell T, Chikritzhs T, Bostrom A, Fillmore K, Kerr W, Rehm J, et al. Alcohol-caused mortality in australia and Canada: scenario analyses using different assumptions about cardiac benefit. J. Stud. Alcohol Drugs 2007;68:345–52.
  242. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, et al. Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br. J. Cancer 2002;87:1234–45.
  243. Tjønneland A, Christensen J, Olsen A, Stripp C, Thomsen BL, Overvad K, et al. Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2007;18:361–73.
  244. Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol Alcohol 2012;47:204–12.
  245. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Light alcohol drinking and cancer: a meta-analysis. Ann. Oncol. 2013;24:301–8.
  246. Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int. J. Cancer 2007;121:2065–72.
  247. Mizoue T, Inoue M, Wakai K, Nagata C, Shimazu T, Tsuji I, et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am. J. Epidemiol. 2008;167:1397–406.
  248. Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann. Intern. Med. 2004;140:603–13.
  249. Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int. J. Cancer 2007;120:664–71.
  250. Akhter M, Kuriyama S, Nakaya N, Shimazu T, Ohmori K, Nishino Y, et al. Alcohol consumption is associated with an increased risk of distal colon and rectal cancer in Japanese men: the Miyagi Cohort Study. Eur. J. Cancer 2007;43:383–90.
  251. Toriola AT, Kurl S, Laukanen JA, Mazengo C, Kauhanen J. Alcohol consumption and risk of colorectal cancer: the Findrink study. Eur. J. Epidemiol. 2008;23:395–401.
  252. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001;38:1112–7.
  253. Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am. J. Epidemiol. 2010;171:633–44.
  254. Marczinski CA, Fillmore MT. Energy drinks mixed with alcohol: what are the risks? Nutr. Rev. 2014;72 Suppl 1:98–107.
  255. Greyling A, Ras RT, Zock PL, Lorenz M, Hopman MT, Thijssen DHJ, et al. The effect of black tea on blood pressure: a systematic review with meta-analysis of randomized controlled trials. PLoS One 2014;9:e103247.
  256. Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr. Metab. Cardiovasc. Dis. 2014;24:823–36.
  257. Khalesi S, Sun J, Buys N, Jamshidi A, Nikbakht-Nasrabadi E, Khosravi-Boroujeni H. Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur. J. Nutr. 2014;53:1299–311.
  258. Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J. Am. Diet. Assoc. 2011;111:1720–9.
  259. Zheng X-X, Xu Y-L, Li S-H, Liu X-X, Hui R, Huang X-H. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am. J. Clin. Nutr. 2011;94:601–10.
  260. Shen L, Song L-G, Ma H, Jin C-N, Wang J-A, Xiang M-X. Tea consumption and risk of stroke: a dose-response meta-analysis of prospective studies. J. Zhejiang Univ. Sci. B 2012;13:652–62.
  261. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009;40:1786–92.
  262. Yang W-S, Wang W-Y, Fan W-Y, Deng Q, Wang X. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br. J. Nutr. 2014;111:1329–39.
  263. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005;81:317S – 325S.
  264. Boganen H, van Hee K, Grundmeijer HGLM. [Hypertension due to liquorice and liquorice tea consumption]. Ned. Tijdschr. Geneeskd. 2007;151:2825–8.
  265. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014;129:643–59.
  266. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 2014;37:569–86.
  267. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu. Rev. Nutr. 1997;17:305–24.
  268. Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 2012;66:872–7.
  269. Koffie en Gezondheid – Home [Internet]. [cited 2015 Nov 30];Available from: http://www.koffieengezondheid.nl/
  270. Scientific Opinion on the safety of caffeine | European Food Safety Authority [Internet]. [cited 2016 Jan 19];Available from: http://www.efsa.europa.eu/en/efsajournal/pub/4102
  271. Chin JM, Merves ML, Goldberger BA, Sampson-Cone A, Cone EJ. Caffeine content of brewed teas. J. Anal. Toxicol. 2008;32:702–4.
  272. Maughan RJ, Griffin J. Caffeine ingestion and fluid balance: a review. J. Hum. Nutr. Diet. 2003;16:411–20.
  273. Killer SC, Blannin AK, Jeukendrup AE. No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population. PLoS One 2014;9:e84154.
  274. Guallar-Castillón P, Rodríguez-Artalejo F, Lopez-Garcia E, León-Muñoz LM, Amiano P, Ardanaz E, et al. Consumption of fried foods and risk of coronary heart disease: Spanish cohort of the European Prospective Investigation into Cancer and Nutrition study. BMJ 2012;344:e363.
  275. Muraki I, Rimm EB, Willett WC, Manson JE, Hu FB, Sun Q. Potato Consumption and Risk of Type 2 Diabetes: Results from Three Prospective Cohort Studies. Diabetes Care [Internet] 2015;Available from: http://dx.doi.org/10.2337/dc15-0547
  276. Bertoia ML, Mukamal KJ, Cahill LE, Hou T, Ludwig DS, Mozaffarian D, et al. Changes in Intake of Fruits and Vegetables and Weight Change in United States Men and Women Followed for Up to 24 Years: Analysis from Three Prospective Cohort Studies. PLoS Med. 2015;12:e1001878.
  277. Consumptie van een aantal voedingsmiddelengroepen en nutriënten door de Nederlandse bevolking [Internet]. [cited 2015 Dec 19];Available from: http://www.rivm.nl/Documenten_en_publicaties/Algemeen_Actueel/Uitgaven/Leefstijl_Voeding/VCP/Consumptie_van_een_aantal_voedingsmiddelengroepen_en_nutri%C3%ABnten_door_de_Nederlandse_bevolking
  278. Aune D, Norat T, Romundstad P, Vatten LJ. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013;28:845–58.
  279. Hu EA, Pan A, Malik V, Sun Q. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. BMJ 2012;344:e1454.
  280. Bazzano LA, Thompson AM, Tees MT, Nguyen CH, Winham DM. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2011;21:94–103.
  281. Ha V, Sievenpiper JL, de Souza RJ, Jayalath VH, Mirrahimi A, Agarwal A, et al. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: a systematic review and meta-analysis of randomized controlled trials. CMAJ 2014;186:E252–62.
  282. WHO. IARC Monographs evaluate consumption of red meat and processed meat [Internet]. [cited 2016 Jan 22];Available from: https://www.iarc.fr/en/media-centre/pr/2015/pdfs/pr240_E.pdf
  283. Kaluza J, Wolk A, Larsson SC. Red meat consumption and risk of stroke: a meta-analysis of prospective studies. Stroke 2012;43:2556–60.
  284. Pan A, Sun Q, Bernstein AM, Manson JE, Willett WC, Hu FB. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern. Med. 2013;173:1328–35.
  285. Feskens EJM, Sluik D, van Woudenbergh GJ. Meat consumption, diabetes, and its complications. Curr. Diab. Rep. 2013;13:298–306.
  286. Chan DSM, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011;6:e20456.
  287. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int. J. Cancer 2009;125:171–80.
  288. Alexander DD, Weed DL, Cushing CA, Lowe KA. Meta-analysis of prospective studies of red meat consumption and colorectal cancer. Eur. J. Cancer Prev. 2011;20:293–307.
  289. Norat T, Chan D, Lau R, Aune D, Vieira R. WCRF/AICR Systematic Literature Review Continuous Update Project Report: The Associations between Food, Nutrition and Physical Activity and the Risk of Colorectal Cancer [Internet]. 2010 [cited 2016 Jan 22];Available from: http://www.wcrf.org/sites/default/files/SLR_colorectal_cancer_2010.pdf
  290. Xue X-J, Gao Q, Qiao J-H, Zhang J, Xu C-P, Liu J. Red and processed meat consumption and the risk of lung cancer: a dose-response meta-analysis of 33 published studies. Int. J. Clin. Exp. Med. 2014;7:1542–53.
  291. Yang WS, Wong MY, Vogtmann E, Tang RQ, Xie L, Yang YS, et al. Meat consumption and risk of lung cancer: evidence from observational studies. Ann. Oncol. 2012;23:3163–70.
  292. Chen G-C, Lv D-B, Pang Z, Liu Q-F. Red and processed meat consumption and risk of stroke: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2013;67:91–5.
  293. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010;121:2271–83.
  294. Spencer EA, Key TJ, Appleby PN, Dahm CC, Keogh RH, Fentiman IS, et al. Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK dietary cohort consortium. Cancer Causes Control 2010;21:1417–25.
  295. Continuous Update Project (CUP) | World Cancer Research Fund International [Internet]. [cited 2016 Jan 22];Available from: http://wcrf.org/int/research-we-fund/continuous-update-project-cup
  296. Lasheras C, González S, Huerta JM, Braga S, Patterson AM, Fernández S. Plasma iron is associated with lipid peroxidation in an elderly population. J. Trace Elem. Med. Biol. 2003;17:171–6.
  297. Hori A, Mizoue T, Kasai H, Kawai K, Matsushita Y, Nanri A, et al. Body iron store as a predictor of oxidative DNA damage in healthy men and women. Cancer Sci. 2010;101:517–22.
  298. Sesink AL, Termont DS, Kleibeuker JH, Van der Meer R. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res. 1999;59:5704–9.
  299. de Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR Jr, et al. Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am. J. Clin. Nutr. 2012;96:397–404.
  300. Honikel K-O. The use and control of nitrate and nitrite for the processing of meat products. Meat Sci. 2008;78:68–76.
  301. Scanlan RA. Formation and occurrence of nitrosamines in food. Cancer Res. 1983;43:2435s – 2440s.
  302. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013;346:f1325.
  303. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer 2008;60:131–44.
  304. Abete I, Romaguera D, Vieira AR, Lopez de Munain A, Norat T. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies. Br. J. Nutr. 2014;112:762–75.
  305. Gascon A, Jacques H, Moorjani S, Deshaies Y, Brun LD, Julien P. Plasma lipoprotein profile and lipolytic activities in response to the substitution of lean white fish for other animal protein sources in premenopausal women. Am. J. Clin. Nutr. 1996;63:315–21.
  306. Hodson L, Skeaff CM, Chisholm WA. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur. J. Clin. Nutr. 2001;55:908–15.
  307. Wolmarans P, Benadé AJ, Kotze TJ, Daubitzer AK, Marais MP, Laubscher R. Plasma lipoprotein response to substituting fish for red meat in the diet. Am. J. Clin. Nutr. 1991;53:1171–6.
  308. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010;122:876–83.
  309. Elton S, O’Higgins P. Medicine and Evolution: Current Applications, Future Prospects. CRC Press; 2008.
  310. Huang T, Yang B, Zheng J, Li G, Wahlqvist ML, Li D. Cardiovascular disease mortality and cancer incidence in vegetarians: a meta-analysis and systematic review. Ann. Nutr. Metab. 2012;60:233–40.
  311. Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, et al. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr. 1998;1:33–41.
  312. Davey GK, Spencer EA, Appleby PN, Allen NE, Knox KH, Key TJ. EPIC–Oxford:lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK. Public Health Nutr. 2003;6:259–68.
  313. Pawlak R, Parrott SJ, Raj S, Cullum-Dugan D, Lucus D. How prevalent is vitamin B(12) deficiency among vegetarians? Nutr. Rev. 2013;71:110–7.
  314. Pawlak R, Lester SE, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur. J. Clin. Nutr. 2014;68:541–8.
  315. Nederlandse Voedsel en waren Autoriteit (NVWA) Monitoring van het gehalte aan keukenzout in vleesvervangers. 2014;22.
  316. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004;109:2705–11.
  317. König A, Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, et al. A quantitative analysis of fish consumption and coronary heart disease mortality. Am. J. Prev. Med. 2005;29:335–46.
  318. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr. Atheroscler. Rep. 2008;10:503–9.
  319. Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15:725–37.
  320. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am. J. Cardiol. 2004;93:1119–23.
  321. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 2004;35:1538–42.
  322. Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, König A, et al. A quantitative analysis of fish consumption and stroke risk. Am. J. Prev. Med. 2005;29:347–52.
  323. Larsson SC, Orsini N. Fish consumption and the risk of stroke: a dose-response meta-analysis. Stroke 2011;42:3621–3.
  324. Xun P, Qin B, Song Y, Nakamura Y, Kurth T, Yaemsiri S, et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2012;66:1199–207.
  325. Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ 2012;345:e6698.
  326. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med. 2002;112:298–304.
  327. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin. Cardiol. 2009;32:365–72.
  328. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008;337:a2931.
  329. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 2011;58:2047–67.
  330. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br. J. Nutr. 2012;107 Suppl 2:S201–13.
  331. Chen Q, Cheng L-Q, Xiao T-H, Zhang Y-X, Zhu M, Zhang R, et al. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Cardiovasc. Drugs Ther. 2011;25:259–65.
  332. Zhao Y-T, Chen Q, Sun Y-X, Li X-B, Zhang P, Xu Y, et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann. Med. 2009;41:301–10.
  333. Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord. 2010;10:24.
  334. Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med. 2010;363:2015–26.
  335. Wu JHY, Mozaffarian D. ω-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle. Heart 2014;100:530–3.
  336. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006;189:19–30.
  337. Bernstein AM, Ding EL, Willett WC, Rimm EB. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J. Nutr. 2012;142:99–104.
  338. Bradberry JC, Hilleman DE. Overview of omega-3 Fatty Acid therapies. P T 2013;38:681–91.
  339. Appleton KM, Sallis HM, Perry R, Ness AR, Churchill R. Omega-3 fatty acids for depression in adults. Cochrane Database Syst. Rev. 2015;11:CD004692.
  340. Sydenham E, Dangour AD, Lim W-S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst. Rev. 2012;6:CD005379.
  341. Wat is duurzame voeding? Het Groene Brein 2015;
  342. Christian C, Ainley D, Bailey M, Dayton P, Hocevar J, LeVine M, et al. A review of formal objections to Marine Stewardship Council fisheries certifications. Biol. Conserv. 2013;161:10–7.
  343. Yeh TS, Hung NH, Lin TC. Analysis of iodine content in seaweed by GC-ECD and estimation of iodine intake. J. Food Drug Anal. 2014;22:189–96.
  344. Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 2014;130:1568–78.
  345. Soedamah-Muthu SS, Verberne LDM, Ding EL, Engberink MF, Geleijnse JM. Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension 2012;60:1131–7.
  346. Buckland G, Gonzalez CA. The role of olive oil in disease prevention: a focus on the recent epidemiological evidence from cohort studies and dietary intervention trials. Br. J. Nutr. 2015;113 Suppl 2:S94–101.
  347. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014;13:154.
  348. Martínez-González MA, Dominguez LJ, Delgado-Rodríguez M. Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case-control, cohort and intervention studies. Br. J. Nutr. 2014;112:248–59.
  349. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 2010;91:535–46.
  350. Hooper L, Abdelhamid A, Moore HJ, Douthwaite W, Skeaff CM, Summerbell CD. Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ 2012;345:e7666.
  351. Huth PJ, Fulgoni VL 3rd, Larson BT. A Systematic Review of High-Oleic Vegetable Oil Substitutions for Other Fats and Oils on Cardiovascular Disease Risk Factors: Implications for Novel High-Oleic Soybean Oils. Adv. Nutr. 2015;6:674–93.
  352. Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst. Rev. 2015;6:CD011737.
  353. Jakobsen MU, O’Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 2009;89:1425–32.
  354. And F. Fats and fatty acids. Available from: http://www.fao.org/3/a-i1953e.pdf
  355. 1969108990001a.pdf. Available from: https://www.ntvg.nl/system/files/publications/1969108990001a.pdf
  356. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:e8707.
  357. Ramsden CE, Ringel A, Feldstein AE, Taha AY, MacIntosh BA, Hibbeln JR, et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot. Essent. Fatty Acids 2012;87:135–41.
  358. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot. Essent. Fatty Acids 2006;75:197–202.
  359. Raphael W, Sordillo LM. Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis. Int. J. Mol. Sci. 2013;14:21167–88.
  360. Goyens PLL, Spilker ME, Zock PL, Katan MB, Mensink RP. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am. J. Clin. Nutr. 2006;84:44–53.
  361. Goyens PLL, Mensink RP. The dietary alpha-linolenic acid to linoleic acid ratio does not affect the serum lipoprotein profile in humans. J. Nutr. 2005;135:2799–804.
  362. Goyens PLL, Mensink RP. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects. Eur. J. Clin. Nutr. 2006;60:978–84.
  363. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155–60.
  364. Muka T, Kiefte-de Jong JC, Hofman A, Dehghan A, Rivadeneira F, Franco OH. Polyunsaturated fatty acids and serum C-reactive protein: the Rotterdam study. Am. J. Epidemiol. 2015;181:846–56.
  365. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr. Atheroscler. Rep. 2010;12:384–90.
  366. Kingwell BA, Chapman MJ, Kontush A, Miller NE. HDL-targeted therapies: progress, failures and future. Nat. Rev. Drug Discov. 2014;13:445–64.
  367. Hovingh GK, Rader DJ, Hegele RA. HDL re-examined. Curr. Opin. Lipidol. 2015;26:127–32.
  368. Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc. Health Risk Manag. 2009;5:757–65.
  369. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013;346:f1326.
  370. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013;346:f1378.
  371. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J. Hum. Hypertens. 2003;17:471–80.
  372. Binia A, Jaeger J, Hu Y, Singh A, Zimmermann D. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J. Hypertens. 2015;33:1509–20.
  373. Nederland de Maat Genomen, 2009 – 2010. 2011;26:015.
  374. Hendriksen MAH, Hoogenveen RT, Hoekstra J, Geleijnse JM, Boshuizen HC, van Raaij JMA. Potential effect of salt reduction in processed foods on health. Am. J. Clin. Nutr. 2014;99:446–53.
  375. Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol. Rev. 2014;66:222–307.
  376. Ikeda K. On the taste of the salt of glutamic acid. Proc. 8th Int. Congr. Appl. Chem 1912;38:147.
  377. Freeman M. Reconsidering the effects of monosodium glutamate: a literature review. J. Am. Acad. Nurse Pract. 2006;18:482–6.
  378. Sahi T. Hypolactasia and lactase persistence. Historical review and the terminology. Scand. J. Gastroenterol. Suppl. 1994;202:1–6.
  379. Rickman JC, Barrett DM, Bruhn CM. Nutritional comparison of fresh, frozen and canned fruits and vegetables. Part 1. Vitamins C and B and phenolic compounds. J. Sci. Food Agric. 2007;87:930–44.
  1. Rickman JC, Bruhn CM, Barrett DM. Nutritional comparison of fresh, frozen, and canned fruits and vegetables II. Vitamin A and carotenoids, vitamin E, minerals and fiber. J. Sci. Food Agric. 2007;87:1185–96
  2. Bauer SR, Ding EL, Smit LA. Cocoa Consumption, Cocoa Flavonoids, and Effects on Cardiovascular Risk Factors: An Evidence-Based Review. Curr. Cardiovasc. Risk Rep. 2011;5:120–7.
  3. Wat zijn de mogelijke gezondheidsgevolgen van alcoholgebruik? – Nationaal Kompas Volksgezondheid [Internet]. [cited 2016 Jan 19];Available from: http://www.nationaalkompas.nl/gezondheidsdeterminanten/leefstijl/alcoholgebruik/wat-zijn-de-mogelijke-gezondheidsgevolgen-van-alcoholgebruik/
  4. Food and Agricultural Organization of The United Nations. livestock’s long shadow Issues, Environmental issues and options. Rome 2006.